Certara Germany GmbH develops and markets industrial software in the field of pharmacometrics and provides consulting and service activities domestically and abroad. The company supplies the BaseCase platform and a visualization tool that dynamically visualizes data for pharmaceutical, medical technology and diagnostics companies. Certara Germany performs sales functions in Europe and earns revenues from both direct sales and transactions handled by Certara US, with Certara US receiving sales commissions and reimbursement of related costs. The company is a subsidiary of Certara, Inc., prepares its financial statements under German commercial law and employed an average of 62 employees in the reporting year.
Entwicklung und Vermarktung industrieller Software im In- und Ausland sowie Erbringung von Beratungsdienstleistungen.
Converted using the official Destatis and Eurostat correspondence tables; ISIC Rev. 4 is the United Nations' international industry classification.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) Berlin (Charlottenburg) Local Court, HRB 123117 (as of 1 November 2026)
| Name | Type | City |
|---|---|---|
| Daniel Corcoran | Geschäftsführer(in) | New York /Vereinigte Staaten |
| Ilse Mommers | Geschäftsführer(in) | Heesch, Niederlande |
Source: German Commercial Register (Handelsregister) Berlin (Charlottenburg) Local Court, HRB 123117 (as of 1 November 2026)
| Date | Event Type | Event |
|---|---|---|
| 20.09.2019 | Business Purpose Update | Entwicklung und Vermarktung industrieller Software im Inund Ausland sowie Erbringung von Beratungsdienstleistungen. |
| 21.12.2018 | Company Name Change | Certara Germany GmbH |
| 21.12.2018 | Gesellschaftsvertrag amended | Gesellschaftsvertrag |
| Date | Type | Change | Total Capital |
|---|---|---|---|
| 17.11.2009 | Share Capital Set | — | 100 € |
Source: German Commercial Register (Handelsregister) Berlin (Charlottenburg) Local Court, HRB 123117 (as of 1 November 2026)
| Year | Revenue | Profit | Balance | Employees |
|---|---|---|---|---|
| 2024 | Rohergebnis€9.5M2 | €679,087 | €10,941,074 | — |
| 2023 | Rohergebnis€10.1M2 | €1,019,908 | €10,906,153 | — |
| 2022 | Rohergebnis€10.8M2 | €2,331,919 | €10,154,224 | — |
| 2021 | Rohergebnis€8.7M2 | €904,205 | €7,199,769 | — |
| 2020 | small company1 | €1,817,499 | €5,645,491 | — |
| 2019 | small company1 | €726,683 | €2,965,931 | — |
| 2018 | small company1 | -€1,670,435 | €1,814,353 | — |
| 2017 | small company1 | €0 | €1,178,782 | — |
| 2016 | small company1 | €119,131 | €2,385,101 | — |
| 2015 | small company1 | €452,551 | €2,227,085 | — |
1 Small companies are not required to publish a profit-and-loss statement (§ 326 (1) HGB). The figure shown is the statutory ceiling under § 267 HGB where the balance-sheet total makes it binding — a company may exceed at most one of the three size criteria.
2 Rohergebnis nach § 276 HGB: Umsatzerlöse abzüglich Materialaufwand bzw. Herstellungskosten. Kleine und mittelgroße Kapitalgesellschaften dürfen diese Posten zusammenfassen; die Umsatzerlöse selbst sind dann nicht veröffentlicht und liegen über dem Rohergebnis.
Sign in to download data
Source: German Commercial Register (Handelsregister) Berlin (Charlottenburg) Local Court, HRB 123117 (as of 1 November 2026)
| Cost type | Amount | Share |
|---|---|---|
| Personnel Costs | €6,115,443 | 90.5% |
| Depreciation | €644,995 | 9.5% |
| Interest & Similar | €62 | 0.0% |
